Last reviewed · How we verify
GSK Bio's Influenza Vaccine GSK576389A — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
GSK Bio's Influenza Vaccine GSK576389A (GSK Bio's Influenza Vaccine GSK576389A) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GSK Bio's Influenza Vaccine GSK576389A TARGET | GSK Bio's Influenza Vaccine GSK576389A | GlaxoSmithKline | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GSK Bio's Influenza Vaccine GSK576389A CI watch — RSS
- GSK Bio's Influenza Vaccine GSK576389A CI watch — Atom
- GSK Bio's Influenza Vaccine GSK576389A CI watch — JSON
- GSK Bio's Influenza Vaccine GSK576389A alone — RSS
Cite this brief
Drug Landscape (2026). GSK Bio's Influenza Vaccine GSK576389A — Competitive Intelligence Brief. https://druglandscape.com/ci/gsk-bio-s-influenza-vaccine-gsk576389a. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab